An Automated Approach To Solving Pharma’s Cardiac Toxicity Conundrum
Posted in Archive
| Tagged ADME / Tox, Analysis, Assay development optimisation & technology, Business, Cell / tissue culture, Cell culture, Cellular & Molecular biology, Cellular assays, Clinical trials, Drug development, Drug discovery, Drug targets, Genetics / genomes, High Content Screening, High throughput screening, Lead discovery, Lead optimisation, Molecular medicine, Pharmacology, Preclinical, Regulatory, RNA, Screening, Stem cells, Target validation, Toxicology
